Clopidogrel and Tegsedi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Tegsedi (inotersen sodium). Common drug interactions include glomerular filtration rate decreased among females and ankle fracture among males.
The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Tegsedi. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
What is Tegsedi?
Tegsedi has active ingredients of inotersen sodium. eHealthMe is studying from 2,040 Tegsedi users. Check the latest studies of Tegsedi.
13 people who take Clopidogrel and Tegsedi together, and have interactions are studied.
What are the common drug interactions of Clopidogrel and Tegsedi, by gender? *:
female:
- Glomerular filtration rate decreased
- Platelet count decreased
- Bacterial test positive
- Nitrite urine present (nitrite in urine)
- Urinary casts
- Urinary sediment present
- Urine abnormality
- Urine protein/creatinine ratio increased
- Red blood cells urine positive
- Anxiety
male:
- Ankle fracture
- Arrhythmia (irregular heartbeat)
- Rash
- Urine protein/creatinine ratio increased
- Abdominal distension
- Cardiac failure
- Infection
- Injection site discolouration
- Peripheral swelling
- Pulmonary oedema (fluid accumulation in the lungs)
What are the common drug interactions of Clopidogrel and Tegsedi, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Platelet count decreased
- Glomerular filtration rate decreased
- Anxiety
- Blood pressure increased
- Constipation
- Crystal urine present
- Decreased appetite
- Dizziness
- Dry mouth
- Gait disturbance
What are the existing conditions these people have? *
- Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 13 people, 100.00%
- Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 15.38%
- Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 2 people, 15.38%
- Magnesium Deficiency (lack of magnesium): 2 people, 15.38%
- Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.69%
- High Blood Pressure: 1 person, 7.69%
- Gout (uric acid crystals building up in the body): 1 person, 7.69%
- Dyspnea (difficult or laboured breathing): 1 person, 7.69%
- Diastolic Dysfunction: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel and Tegsedi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Clopidogrel (92,160 reports)
- Tegsedi (2,040 reports)
Browse all drug interactions of Clopidogrel and Tegsedi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tegsedi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clopidogrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tegsedi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on clopidogrel and inotersen sodium (the active ingredients of Clopidogrel and Tegsedi, respectively), and Clopidogrel and Tegsedi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Protamine Sulfate cause Ejection Fraction Decreased? - 2 seconds ago
- Could Tamsulosin cause Hair Growth Abnormal? - 4 seconds ago
- Drug interactions of Tegretol and Mestinon - 14 seconds ago
- Could Meclizine cause Dyslipidaemia? - 19 seconds ago
- Drug interactions of Clarithromycin and Panthenol - 41 seconds ago
- Could Gabapentin cause Nail Abnormalities? - 42 seconds ago
- Drug interactions of Lyrica and Axitinib - a minute ago
- Could Compazine cause Chronic Obstructive Pulmonary Disease? - a minute ago
- Drug interactions of Coq and Testosterone - a minute ago
- Could Glucovance cause Sweating Increased? - a minute ago